Pfizer returns asthma drug development to Rigel – BusinessWeek

Pfizer returns asthma drug development to Rigel
BusinessWeek
Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage company said

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *